# Training-Free Clinical Reasoning through Medical Ontologies and Cognitive Mapping: A Symbolic-Probabilistic Knowledge Graph Framework

arXiv: https://arxiv.org/abs/2609.35298 · HTML: https://mlsanity.com/paper/2609.35298/

## Key facts

- No citing papers in the map yet (data through 14 Oct 2026).
- Placed in Clinical and biomedical applications, one of 17 directions in LLM reasoning.
- Builds on 2 of its 35 references that are in the map.
- First posted on arXiv 28 Sep 2026.

## Placed in

- LLM reasoning / [Clinical and biomedical applications](https://mlsanity.com/lr/clinical-and-biomedical-applications/)

## Builds on (most cited first, 2 of 2)

- [Leveraging Medical Knowledge Graphs Into Large Language Models for Diagnosis Prediction: Design and Application Study](https://mlsanity.com/paper/2308.14321/) (2023)
- [Refining Diagnosis Paths for Medical Diagnosis based on an Augmented Knowledge Graph](https://mlsanity.com/paper/2204.13329/) (2022)

## Abstract (arXiv)

Most clinical prediction systems learn patient-variable-outcome associations; we investigate a training-free diagnostic paradigm mapping patient observations to explicit medical knowledge. CKG Reasoner integrates candidate-specific Evidence Feature Nodes, patient-reference matching, a bounded Information Gate, knowledge-weighted evidence accumulation, disease similarity, and decisive clinical rules. Missing-aware normalization and coverage auditing distinguish absent from unavailable evidence. Candidate ranking is separate from outcome-label-independent K-means clustering, which uses four derived evidence coordinates (evidence strength, relative magnitude, directional similarity, and evidence completeness), not raw predictors or targets, to derive cohort-level assignments. Across six retrospective cohorts - four dengue (N = 1000, 1523, 989, 1018), malaria (N = 2190), and influenza (N = 4569) - a uniform, label-free, cohort-fitted K = 2 protocol yielded positive-class F1 scores of 0.996, 0.634, 0.936, 0.917, 0.695, and 0.842, and all-record accuracies of 0.996, 0.558, 0.914, 0.893, 0.707, and 0.906, respectively, with full partition-decision coverage using the frozen package and disease-specific knowledge representations. Neither scoring nor clustering uses outcome labels. Logistic regression provides a supervised baseline. Influenza incorporates confirmatory molecular PCR and is not independent pre-test prediction. Results characterize knowledge-grounded evidence separation, auditability, and sensitivity, not prospective clinical validity or comparative superiority. FOL/LLM-based clinical explanation remains unevaluated.
